S&P 500
(0.13%) 5 106.61 points
Dow Jones
(0.13%) 38 291 points
Nasdaq
(0.12%) 15 947 points
Oil
(-1.25%) $82.80
Gas
(4.94%) $2.02
Gold
(0.08%) $2 349.10
Silver
(0.06%) $27.55
Platinum
(3.88%) $957.90
USD/EUR
(-0.17%) $0.933
USD/NOK
(-0.23%) $11.00
USD/GBP
(-0.44%) $0.797
USD/RUB
(1.74%) $93.47

实时更新: Neurogene Inc. [NGNE]

交易所: NASDAQ Global Market 部门: Healthcare 工业: Biotechnology
BUY
100.00%
return 7.03%
SELL
0.00%
return 11.65%
最后更新时间29 Apr 2024 @ 23:38

7.93% $ 32.34

购买 110563 min ago

@ $29.19

发出时间: 13 Feb 2024 @ 04:57


回报率: 10.77%


上一信号: Feb 12 - 22:41


上一信号: 出售


回报率: -10.43 %

Live Chart Being Loaded With Signals

Commentary (29 Apr 2024 @ 23:38):

Neurogene Inc. develops life-changing genetic medicines for patients and their families affected by neurological diseases. Its product candidate includes NGN-401, an investigational AAV9 gene therapy for the treatment of Rett syndrome; and NGN-101 to treat neuronal ceroid lipofuscinosis subtype 5 batten disease...

Stats
今日成交量 27 627.00
平均成交量 140 206
市值 415.60M
EPS $-1.510 ( 2024-04-02 )
下一个收益日期 ( $-1.030 ) 2024-05-06
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E 0
ATR14 $0.217 (0.67%)
Insider Trading
Date Person Action Amount type
2024-03-13 Mcminn Rachel Buy 93 282 Employee Stock Option (Right to buy)
2024-03-13 Cvijic Christine Mikail Buy 53 900 Employee Stock Option (Right to buy)
2024-03-13 Cvijic Christine Mikail Buy 31 903 Common Stock
2024-03-13 Cobb Stuart Buy 34 450 Stock Option (Right to Buy)
2024-03-13 Cobb Stuart Buy 20 391 Common Stock
INSIDER POWER
100.00
Last 13 transactions
Buy: 3 111 176 | Sell: 0

音量 相关性

長: 0.00 (neutral)
短: -0.06 (neutral)
Signal:(52.164) Neutral

Neurogene Inc. 相关性

10 最正相关
10 最负相关

你知道吗?

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。

相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Neurogene Inc. 相关性 - 货币/商品

The country flag 0.21
( neutral )
The country flag 0.71
( moderate )
The country flag 0.08
( neutral )
The country flag 0.65
( weak )
The country flag -0.36
( neutral )
The country flag -0.12
( neutral )

Neurogene Inc. 财务报表

Annual 2023
营收: $0
毛利润: $-3.26M (0.00 %)
EPS: $-2.83
FY 2023
营收: $0
毛利润: $-3.26M (0.00 %)
EPS: $-2.83

Financial Reports:

No articles found.

Neurogene Inc.

Neurogene Inc. develops life-changing genetic medicines for patients and their families affected by neurological diseases. Its product candidate includes NGN-401, an investigational AAV9 gene therapy for the treatment of Rett syndrome; and NGN-101 to treat neuronal ceroid lipofuscinosis subtype 5 batten disease. The company is headquartered in New York, New York.

关于 实时信号

此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。

实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。